These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 28352306)
1. Risk of cardiovascular disease in inflammatory bowel disease. Wu P; Jia F; Zhang B; Zhang P Exp Ther Med; 2017 Feb; 13(2):395-400. PubMed ID: 28352306 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory bowel disease and cardiovascular diseases: a concise review. Wu H; Hu T; Hao H; Hill MA; Xu C; Liu Z Eur Heart J Open; 2022 Jan; 2(1):oeab029. PubMed ID: 35919661 [TBL] [Abstract][Full Text] [Related]
3. Ischemic Heart Disease in Patients with Inflammatory Bowel Disease: Risk Factors, Mechanisms and Prevention. Jucan AE; Gavrilescu O; Dranga M; Popa IV; Mihai BM; Prelipcean CC; Mihai C Life (Basel); 2022 Jul; 12(8):. PubMed ID: 35892915 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease? Bigeh A; Sanchez A; Maestas C; Gulati M Trends Cardiovasc Med; 2020 Nov; 30(8):463-469. PubMed ID: 31653485 [TBL] [Abstract][Full Text] [Related]
5. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138 [TBL] [Abstract][Full Text] [Related]
6. The oft-overlooked cardiovascular complications of inflammatory bowel disease. Massironi S; Mulinacci G; Gallo C; Viganò C; Fichera M; Villatore A; Peretto G; Danese S Expert Rev Clin Immunol; 2023 Apr; 19(4):375-391. PubMed ID: 36722283 [TBL] [Abstract][Full Text] [Related]
7. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies. Magro F; Portela F BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228 [TBL] [Abstract][Full Text] [Related]
8. Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management. Sleutjes JAM; van Lennep JER; van der Woude CJ; de Vries AC Therap Adv Gastroenterol; 2021; 14():17562848211032126. PubMed ID: 34377149 [TBL] [Abstract][Full Text] [Related]
20. Is there a cardiovascular risk in inflammatory bowel diseases? Mitu O; Alexandrescu DM; Cătălina M; Cristina CP Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):918-23. PubMed ID: 25581948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]